Stay updated on Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial

Sign up to get notified when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page's revision tag was updated from Revision: v3.5.3 to Revision: v3.5.4, signaling a new build of the page. This update appears to be a minor site release and does not modify the study details or content displayed on the page.
    Difference
    0.1%
    Check dated 2026-05-15T06:21:42.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page’s footer software/version indicator has been updated from “Revision: v3.5.2” to “Revision: v3.5.3.”
    Difference
    0.1%
    Check dated 2026-04-24T06:41:09.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No changes to the study details or data are visible.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:45.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:13:11.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, and Revision: v3.4.2 was removed from the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:40:49.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The government funding status notice and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T12:30:59.000Z thumbnail image

Stay in the know with updates to Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.